 Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks Biotech Stocks Hitting 52-week highs on March 2 Forty Seven Inc NASDAQ: FTSV announced a deal to be bought by Gilead Sciences, Inc. NASDAQ: GILD IGM Biosciences Inc NASDAQ: IGMS Iovance Biotherapeutics Inc NASDAQ: IOVA Karyopharm Therapeutics Inc NASDAQ: KPTI announced positive late-stage results for selinexor Passage Bio Inc NASDAQ: PASG IPOed Friday Syneos Health Inc NASDAQ: SYNH Trillium Therapeutics Inc NASDAQ: TRIL moved in sympathy with Forty Seven, as it has a similar drug in the pipeline for solid tumor Zynex Inc. NASDAQ: ZYXI Down In The Dumps Biotech Stocks Hitting 52-week lows on March 2 Aerie Pharmaceuticals Inc NASDAQ: AERI AEterna Zentaris Inc. NASDAQ: AEZS Akorn, Inc. NASDAQ: AKRX ANI Pharmaceuticals Inc NASDAQ: ANIP moved lower despite FDA nod for a generic version of Teva Pharmaceutical Industries Ltds NYSE: TEVA Alzheimers related dementia drug Autolus Therapeutics Ltd ADR NASDAQ: AUTL Axovant Gene Therapies Ltd NASDAQ: AXGT Black Diamond Therapeutics Inc NASDAQ: BDTX Eagle Pharmaceuticals Inc NASDAQ: EGRX reacted to its fourth-quarter results Evolus Inc NASDAQ: EOLS EXACT Sciences Corporation NASDAQ: EXAS GenMark Diagnostics, Inc NASDAQ: GNMK Imv Inc NASDAQ: IMV Neurometrix Inc NASDAQ: NURO Portola Pharmaceuticals Inc NASDAQ: PTLA Precigen Inc NASDAQ: PGEN Taro Pharmaceutical Industries Ltd. NYSE: TARO Tetraphase Pharmaceuticals Inc NASDAQ: TTPH TherapeuticsMD Inc NASDAQ: TXMD Vanda Pharmaceuticals Inc. NASDAQ: VNDA Viking Therapeutics Inc NASDAQ: VKTX Related Link: How The COVID-19 Outbreak Is Benefiting Biotech Investors Stocks In Focus GenMark Starts Shipping COVID-19 Test Kits GenMark said it has begun shipping ePlex Research Use Only, or RUO, test kits to detect COVID-19 virus. 